Innovation and research

Our team of clinicians and embryologists regularly attend lectures, workshops, and conferences around the world to represent ARGC and share their experience with other professionals in the field of assisted reproduction.

The ARGC was awarded a research licence (Project Reference R0165) to investigate immunological factors of implantation and embryo development. The findings supported our clinic practice and were published in peer review journals.

ARGC’s Publications:

Some ARGC’s patients, who have completed their families, consent for their frozen embryos (which are no longer required for their treatment) to be available for research. To assist these patients we have set up a collaboration with the Francis Crick Institute in London, which is the first centre to have received permission from the HFEA to use the genome-editing technique, ‘CRISPR-Cas9’, in human embryos. This technique will allow a better understanding of the earliest stages of human development.